The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current ...